EUVIMEDEUVIMED entdecken
Crossref

Decreased Levels of Anti-Aging Klotho in Obstructive Sleep Apnea

Judit Pákó, László Kunos, Martina Mészáros, Dávid László Tárnoki, Ádám Domonkos Tárnoki, Ildikó Horváth, András Bikov

Rejuvenation Research · 2020-06 · 23 (3) · 256-261

DOI: 10.1089/rej.2019.2183 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Rejuvenation Research, online erschienen am 16.06.2020. Verfasst von Judit Pákó und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology, National Koranyi Institute for Pulmonology, Budapest, Hungary. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The klotho protein is secreted primarily by the kidneys. It is responsible for phosphate homeostasis and has an anti-aging, anti-inflammatory, and anti-oxidative stress role. Obstructive sleep apnea (OSA) is associated with an enhanced systemic inflammation and oxidative stress, but mechanisms that regulate these processes are poorly understood. The aim of the study was to investigate the plasma levels of klotho in OSA. Twenty-one previously untreated patients with OSA (56 ± 13 years, 12 males) and 41 non-OSA control volunteers (48 ± 16 years, 8 males) participated in the study. Medical history has been taken; participants filled out the Epworth Sleepiness Scale. C-reactive protein and renal function, glucose and lipid profile measurements were performed in sera; klotho was determined in citrate-treated plasma samples. Levels of plasma klotho were decreased in OSA (519.1 ± 164.9 pg/mL) versus controls (700.8 ± 431.4 pg/mL, p = 0.02). Reduced klotho concentrations were associated with markers of overnight hypoxemia determined with O 2 desaturation index ( r = −0.31, p = 0.01), percentage of sleep time spent with saturation 0.05). Significant association was also found between low plasma klotho levels and the presence of hypertension ( p < 0.05). Our results suggest that chronic intermittent hypoxia reduces the levels of klotho in OSA, which may contribute to the development of hypertension. Decreased klotho levels may play a role in enhanced systemic inflammation in OSA and may be a future target for drug development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdultAgedAgingBiomarkersCase-Control StudiesDown-RegulationFemaleGlucuronidaseHumansInflammationKlotho ProteinsMaleMiddle AgedOxidative StressPolysomnographySeverity of Illness IndexSleepSleep Apnea, Obstructive

Stichwörter der Autor:innen

biomarkershypoxiainflammationklotho proteinobstructivesleep apnea

Substanzen

BiomarkersGlucuronidaseKlotho Proteins

Autor:innen und Institutionen

  • Department of Pathophysiology, National Koranyi Institute for Pulmonology, Budapest, Hungary.
  • Department of Pulmonology, Semmelweis University, Budapest, Hungary.
  • Department of Radiology, Semmelweis University, Budapest, Hungary.
  • Manchester Clinical Research Facility, Manchester University NHS Foundation Trust, Manchester, United Kingdom.

Zitieren

APA

Pákó, J., Kunos, L., Mészáros, M., Tárnoki, D. L., Tárnoki, Á. D., Horváth, I., & Bikov, A. (2020). Decreased Levels of Anti-Aging Klotho in Obstructive Sleep Apnea. Rejuvenation Research, 23(3), 256-261. https://doi.org/10.1089/rej.2019.2183

Vancouver

Pákó J, Kunos L, Mészáros M, Tárnoki DL, Tárnoki ÁD, Horváth I, et al. Decreased Levels of Anti-Aging Klotho in Obstructive Sleep Apnea. Rejuvenation Research. 2020;23(3):256-261. doi:10.1089/rej.2019.2183

BibTeX
@article{Pk2020,
  author = {Pákó, Judit and Kunos, László and Mészáros, Martina and Tárnoki, Dávid László and Tárnoki, Ádám Domonkos and Horváth, Ildikó and Bikov, András},
  title = {Decreased Levels of Anti-Aging Klotho in Obstructive Sleep Apnea},
  journal = {Rejuvenation Research},
  year = {2020},
  volume = {23},
  number = {3},
  pages = {256--261},
  doi = {10.1089/rej.2019.2183}
}
Kostenlos starten →